Finance Monthly CFO Awards 2019 Winners Edition

COUNTRY EVP & CFO of Sanofi JEAN-BAPTISTE CHASSELOUP DE CHATILLON ABOUT JEAN-BAPTISTE CHASSELOUP DE CHATILLON Jean-Baptiste Chasseloup de Chatillon holds a Masters from Paris Dauphine University and studied Finance in the United Kingdom at Lancaster University. Until recently, he served as Chief Financial Officer and Executive Vice President of the PSA Group. In that capacity, he was also a member of the Managing Board and Executive Committee. He held various management positions within the PSA Group in finance (Treasurer in Spain, Chief Financial Officer in the United Kingdom) and in sales and marketing (Citroen Belgium Managing Director). He was also Chairman of the Board of Banque PSA Finance (BPF) from 2012 to June 2016. He joined the Peugeot S.A. Managing Board in 2012. He was appointed to his current post on October 1, 2018. FIRM PROFILE Sanofi S.A. is a French multinational pharmaceutical company headquartered in Paris, France. We are people, patients, parents, caregivers, researchers… Together, we are Sanofi, a healthcare organization dedicated to improving the lives of people worldwide. Our teams work with passion and commitment to understand and solve everyone’s healthcare needs. We transform scientific innovation into healthcare solutions, accept challenges and challenge the accepted. We have the courage to fight for equal opportunity and to speak out against discrimination. We believe that better health begins with education. We believe that empowering individuals, the community and healthcare professionals to promote and practice self-care, will lead to people all over the world being healthier. Our self-care solutions cover cough and cold, allergies, digestive health, nutritionals and pain care. We have a strong heritage in oncology and are committed to finding new pathways to treat people affected by the disease and improve their quality of life. We, at Sanofi, believe that open innovation will help develop new approaches and expertise to discover targeted treatments against cancer AT A GLANCE 75 Manufacturing sites in 33 countries €5,849M Invested in research & development in 2018 81 projects in development 4 R&D hubs across Europe, North America & Asia Finance Monthly CFO Awards 2019 20 FRA CE Finance Monthly CFO Awards 2019

RkJQdWJsaXNoZXIy Mjk3Mzkz